Companies Racing to Use CRISPR to Fight Disease

While a research assistant at the Harvard School of Public Health, Ashley performed genetic engineering projects using the CRISPR Cas-9 system. She continues using this gene-editing tool in her current research in Cambridge biotech, CRISPR Tx.  

Posters & Publications:

Padalia,Zinkal, Porras, Ashley. "Production of site-specific Allogeneic CD19 CAR-T Cells by CRISPR-Cas9 for B-Cell Malignancies." Society for Immunotherapy of Cancer Conference. Cellular Therapies Poster Session. 9-12 Nov. 2017. National Harbor, MD, USA. 

Wang, Huajin. "Seipin Is Required for Converting Nascent to Mature Lipid Droplets." ELife. ELife Sciences Publications, 26 Aug. 2016. Web.<>.                        

Pub Med ID: 27564575